These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 14507672)

  • 21. Activation of autophagy is required for Oroxylin A to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
    Chen W; Zhang Z; Yao Z; Wang L; Zhang F; Shao J; Chen A; Zheng S
    Int Immunopharmacol; 2018 Mar; 56():148-155. PubMed ID: 29414645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foxf1 +/- mice exhibit defective stellate cell activation and abnormal liver regeneration following CCl4 injury.
    Kalinichenko VV; Bhattacharyya D; Zhou Y; Gusarova GA; Kim W; Shin B; Costa RH
    Hepatology; 2003 Jan; 37(1):107-17. PubMed ID: 12500195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo.
    Hellerbrand C; Stefanovic B; Giordano F; Burchardt ER; Brenner DA
    J Hepatol; 1999 Jan; 30(1):77-87. PubMed ID: 9927153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.
    George J; Tsutsumi M; Tsuchishima M
    J Cell Mol Med; 2017 Dec; 21(12):3821-3835. PubMed ID: 28782260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride.
    Simeonova PP; Gallucci RM; Hulderman T; Wilson R; Kommineni C; Rao M; Luster MI
    Toxicol Appl Pharmacol; 2001 Dec; 177(2):112-20. PubMed ID: 11740910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2.
    Ikeda H; Watanabe N; Ishii I; Shimosawa T; Kume Y; Tomiya T; Inoue Y; Nishikawa T; Ohtomo N; Tanoue Y; Iitsuka S; Fujita R; Omata M; Chun J; Yatomi Y
    J Lipid Res; 2009 Mar; 50(3):556-564. PubMed ID: 18955732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
    Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride.
    Kon K; Ikejima K; Hirose M; Yoshikawa M; Enomoto N; Kitamura T; Takei Y; Sato N
    Biochem Biophys Res Commun; 2002 Feb; 291(1):55-61. PubMed ID: 11829461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.
    Lamb CL; Cholico GN; Pu X; Hagler GD; Cornell KA; Mitchell KA
    Toxicol Appl Pharmacol; 2016 Nov; 311():42-51. PubMed ID: 27693115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice.
    Geng Y; Sun Q; Li W; Lu ZM; Xu HY; Shi JS; Xu ZH
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27983763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat.
    Abe W; Ikejima K; Lang T; Okumura K; Enomoto N; Kitamura T; Takei Y; Sato N
    J Hepatol; 2007 Feb; 46(2):286-94. PubMed ID: 17166617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte-specific ablation of PP2A catalytic subunit α attenuates liver fibrosis progression via TGF-β1/Smad signaling.
    Lu N; Liu Y; Tang A; Chen L; Miao D; Yuan X
    Biomed Res Int; 2015; 2015():794862. PubMed ID: 25710025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gypenosides Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the Differentiation of Hepatic Progenitor Cells into Myofibroblasts.
    Chen J; Li X; Hu Y; Liu W; Zhou Q; Zhang H; Mu Y; Liu P
    Am J Chin Med; 2017; 45(5):1061-1074. PubMed ID: 28659031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
    França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
    Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.
    Park O; Jeong WI; Wang L; Wang H; Lian ZX; Gershwin ME; Gao B
    Hepatology; 2009 May; 49(5):1683-94. PubMed ID: 19205035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl
    Ji DG; Zhang Y; Yao SM; Zhai XJ; Zhang LR; Zhang YZ; Li H
    Biomed Pharmacother; 2018 Jun; 102():26-33. PubMed ID: 29549726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
    Ai WL; Dong LY; Wang J; Li ZW; Wang X; Gao J; Wu Y; An W
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3780-3791. PubMed ID: 30251695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of Anluohuaxianwan on transforming growth factor-β1 and related signaling pathways in rats with carbon tetrachloride-induced liver fibrosis].
    Lu W; Gao YH; Wang ZZ; Cai YS; Yang YQ; Miao YQ; Pei F; Liu XE; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):257-262. PubMed ID: 28494543
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral administration of recombinant adeno-associated virus-mediated bone morphogenetic protein-7 suppresses CCl(4)-induced hepatic fibrosis in mice.
    Hao ZM; Cai M; Lv YF; Huang YH; Li HH
    Mol Ther; 2012 Nov; 20(11):2043-51. PubMed ID: 22850680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.